Dopamine-mediated activation of the human progesterone receptor.
Philpott
A J
AJ
Department of Pharmacology, Organon Laboratories, Ltd., Larnarkshire, UK.
Shahid
M
M
D015647:2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine / Q000494:pharmacology; D015124:8-Bromo Cyclic Adenosine Monophosphate / Q000494:pharmacology; D000818:Animals; D002478:Cells, Cultured; D002645:Chickens; D002522:Chlorocebus aethiops; D000242:Cyclic AMP / Q000502:physiology; D017868:Cyclic AMP-Dependent Protein Kinases / Q000378:metabolism; D004298:Dopamine / Q000494:pharmacology*; D018491:Dopamine Agonists / Q000494:pharmacology; D005786:Gene Expression Regulation / Q000187:drug effects*; D017930:Genes, Reporter; D006801:Humans; D010766:Phosphorylation; D011499:Protein Processing, Post-Translational; D017447:Receptors, Dopamine D1 / Q000187:drug effects / Q000502:physiology; D011965:Receptors, Glucocorticoid / Q000187:drug effects / Q000502:physiology; D011980:Receptors, Progesterone / Q000187:drug effects* / Q000235:genetics / Q000502:physiology; D015290:Second Messenger Systems / Q000187:drug effects / Q000502:physiology; D013045:Species Specificity; D014162:Transfection
D018491:Dopamine Agonists; D017447:Receptors, Dopamine D1; D011965:Receptors, Glucocorticoid; D011980:Receptors, Progesterone; D015124:8-Bromo Cyclic Adenosine Monophosphate; D015647:2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; D000242:Cyclic AMP; D017868:Cyclic AMP-Dependent Protein Kinases; D004298:Dopamine